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Abstract: The dematiaceous (melanised) fungus Lomentospora (Scedosporium) prolificans is
a life-threatening opportunistic pathogen of immunocompromised humans, resistant to anti-fungal
drugs. Melanin has been shown to protect human pathogenic fungi against antifungal drugs, oxidative
killing and environmental stresses. To determine the protective role of melanin in L. prolificans to
oxidative killing (H2O2), UV radiation and the polyene anti-fungal drug amphotericin B, targeted
gene disruption was used to generate mutants of the pathogen lacking the dihydroxynaphthalene
(DHN)-melanin biosynthetic enzymes polyketide synthase (PKS1), tetrahydroxynapthalene reductase
(4HNR) and scytalone dehydratase (SCD1). Infectious propagules (spores) of the wild-type strain
3.1 were black/brown, whereas spores of the PKS-deficient mutant DLppks1::hph were white.
Complementation of the albino mutant DLppks1::hph restored the black-brown spore pigmentation,
while the 4HNR-deficient mutant DLp4hnr::hph and SCD-deficient mutant DLpscd1::hph both produced
orange-yellow spores. The mutants DLppks1::hph and DLp4hnr::hph showed significant reductions
in spore survival following H2O2 treatment, while spores of DLpscd1::hph and the DLppks1::hph
complemented strain DLppks1::hph:PKS showed spore survivals similar to strain 3.1. Spores of the
mutants DLp4hnr::hph and DLpscd1::hph and complemented strain DLppks1::hph:PKS showed spore
survivals similar to 3.1 following exposure to UV radiation, but survival of DLppks1::hph spores was
significantly reduced compared to the wild-type strain. Strain 3.1 and mutants DLp4hnr::hph and
DLppks1::hph:PKS were resistant to amphotericin B while, paradoxically, the PKS1- and SCD1-deficient
mutants showed significant increases in growth in the presence of the antifungal drug. Taken together,
these results show that while melanin plays a protective role in the survival of the pathogen to
oxidative killing and UV radiation, melanin does not contribute to its resistance to amphotericin B.
Keywords: Lomentospora; melanin; fungus; pathogen; scytalone dehydratase; polyketide synthase;
tetrahydroxynaphthalene reductase; gene
1. Introduction
Lomentospora prolificans (formally Scedosporium prolificans) is a dematiaceous (melanised)
fungus that has emerged over recent years as a serious and often life-threatening pathogen of
immunocompromised individuals including those with AIDS, haematological malignancies and bone
marrow and solid organ transplants [1–8]. In neutropenic patients, deep-seated infections disseminate
rapidly with associated mortality rates of up to 80% [1,9]. Infections due to near-drowning were
reported by the World Health Organisation after the Great Eastern Japan earthquake and tsunami
in 2011 [10,11]. Recovery of L. prolificans from the sputum of cystic fibrosis patients has also been
reported, but disease exacerbation due to the fungus has yet to be established [12].
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A characteristic of L. prolificans and other dematiaceous human pathogenic fungi, which accounts
for high patient mortalities, is their widespread resistance to systemic anti-fungal drugs currently
available in the clinic including the broad-spectrum polyene macrolide amphotericin B, the first line
therapy for a number of invasive mycoses [13–18]. In vitro drug susceptibilities of these melanised
fungi are typically lower than for non-melanised fungi and the protective role of melanin in antifungal
drug resistance and to environmental stresses has been advocated [19–23]. Melanin has been shown
to protect fungal pathogens against the antifungal drug amphotericin B [19,24,25], oxidative killing
of infectious propagules [22,26–29], destruction of propagules by phagocytic cells of the immune
system [22,25,30], antimicrobial peptides [31] and can confer tolerance against UV, solar and gamma
radiations [25,32,33]. Furthermore, melanin has been shown to be an important virulence factor in
both plant and human pathogenic fungi [22,25,28,34,35].
As with many other dematiaceous fungi, Lomentospora prolificans produces the polymer
dihydroxynaphthalene (DHN)-melanin via a biosynthetic pathway (Figure 1A) that starts with the
precursor malonyl-CoA [22,36,37]. The first step (Figure 1A, step [1]) in the pathway is catalysed by the
enzyme polyketide synthase (PKS1), which converts malonyl-CoA to 1,3,6,8-tetrahydroxynaphthalene
(1,3,6,8-THN). 1,3,6,8-THN is reduced by the enzyme tetrahydroxynapthalene reductase (4HNR) to
scytalone (Figure 1A step [2]). Scytalone is then dehydrated enzymatically by scytalone dehydratase
(SCD1) to 1,3,8-trihydroxynaphthalene (Figure 1A, step [3]), which is in turn reduced, possibly by
a second reductase, to vermelone. A further dehydration step, possibly also catalysed by SCD1, leads
to the intermediate 1,8-DHN. Subsequent steps are thought to involve dimerization of the 1,8-DHN
molecules followed by polymerisation.
In a previous study [38], we reported the generation of a monoclonal antibody specific to
L. prolificans and identified its antigen through mass spectrometry and targeted gene disruption
as the melanin biosynthetic enzyme 1,3,6,8-tetrahydroxynapthalene reductase [38]. As an extension
to this study, we set out here to determine the role of this enzyme and two other enzymes involved
in DHN-melanin production (scytalone dehydratase and polyketide synthase) in melanisation of
L. prolificans and to investigate the consequences of enzyme loss for the survival of the pathogen.
To this end, we use targeted disruption of polyketide synthase and scytalone dehydratase-encoding
genes to generate enzyme-deficient mutants of the fungus and determine their sensitivities and that
of the tetrahydroxynapthalene reductase-deficient mutant [38] to stresses incurred by UV radiation,
oxidative killing and amphotericin B. Using this strategy, we show that melanin confers tolerance
of the fungus to UV and oxidative killing, but does not contribute to its resistance to the polyene
anti-fungal drug.
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Figure 1. Southern blot analysis of targeted scytalone dehydratase 1 (SCD1) and polyketide synthase
(PKS1) gene replace ents and PKS1 co ple entation and resultant phenotypes of DLpscd1::hph,
DLppks1::hph and DLppks1::hph:PKS mutants. (A) Schematic diagram showing the three different
steps of dihydroxynaphthalene (DHN)-melanin biosynthesis disrupted by targeted gene deletion in
this study. Targeted disruption of PKS1 (step [1]) prevents production of the melanin precursor
1,3,6,8-tetrahydroxynaphthalene (1,3,6,8-THN), disruption of tetrahydroxynapthalene reductase
(4HNR) (step [2]) prevents reduction of 1,3,6,8-THN to scytalone and disruption of SCD1 (step [3])
prevents dehydration of scytalone to 1,3,8-THN; (B) Genomic DNA of the L. prolificans wild-type
strain 3.1 (lane 1) and the putative transformant DLpscd1::hph (lane 3) were digested with the restriction
enzyme BglII, fractionated by gel electrophoresis and blotted onto Hybond-NX membrane; (C) Lane L
contains DNA size marker and lane 2 was left blank. The membrane was probed with a 1.0-kb fragment
upstream of the SCD1 ORF. The presence of the single 6.9-kb band in lane 3, compared to the single
5.7-kb band in lane 1, indicates successful replacement of the SCD1 gene; (D) Colony morphology
of strain 3.1 after 2-week growth on oatmeal agar (OA) at 30 ˝C showing typical grey phenotype;
(E) Morphology of mutant DLpscd1::hph after 2-weeks growth on OA at 30 ˝C showing abnormal
beige pigmentation and comparison to the yellow-grey tetrahydroxynaphthalene reductase-deficient
mutant DLp4hnr::hph (F) developed previously [38]. Scales bars in D–F = 1.5 cm; (G) Genomic DNA
of wild-type strain 3.1 (lane 1) and putative DLppks1::hph transformants (lanes 2 to 7) were digested
with the restriction enzyme HpaI, fractionated by gel electrophoresis and blotted onto Hybond-NX
membrane. Lane L contains DNA size marker; (H) The membrane was probed with a 1.9-kb right
flank fragment of the PKS1 ORF. The presence of single 5.6-kb bands in lanes 5 and 7 (indicated by
white asterisks), compared to the single 6.5-kb band in lane 1 (indicated by black asterisk), indicates
successful replacement of the PKS1 gene in these two strains; (I) Colony morphology of wild-type
strain 3.1 after 2-weeks growth on OA at 30 ˝C showing typical grey phenotype; (J) Morphology
of the putative DLppks::hph mutant corresponding to lane 7 of the Southern blot shown in panel H,
after 2-weeks growth on OA at 30 ˝C. Note the albino phenotype and complete loss of pigmentation.
Scales bars in I and J = 1.5 cm; (K) Genomic DNA of strain 3.1 (lane 1), the two DLppks1::hphmutants
corresponding to lanes 5 and 7 of the Southern blot shown in panelH (lanes 2 and 3) and a putative
DLppks1::hph:PKS complemented strain (lane 4) derived from the DLppks1::hphmutant shown in lane
7 of the Southern blot in panelH. DNA was digested with the restriction enzyme BglII, fractionated
by gel electrophoresis and blotted onto Hybond-NX membrane; (L) Lane L is DNA size marker.
The membrane was probed with a 0.8-kb fragment of the PKS1 ORF. The presence of a single 7.3-kb
band in lane 4 (comparable to lane 1) indicates successful complementation of the DLppks1::hphmutant
and production of the complemented strain DLppks1::hph:PKS; and (M) Colony morphology of the
DLppks1::hph complemented strain DLppks1::hph:PKS after 2-weeks growth on OA at 30 ˝C, showing
restoration of melanin production and a grey phenotype similar to that of the wild-type strain 3.1
(D and I). Scale bar = 1.5 cm.
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2. Results
2.1. Targeted Disruption of L. prolificans Melanin Biosynthesis Genes and Recovery of Putative Mutants
In this study, we used targeted gene replacement to disrupt production of the enzymes polyketide
synthase (PKS) and scytalone dehydratase (SCD) that catalyse steps [1] and [3] of DHN-melanin
biosynthesis in L. prolificans as shown in Figure 1A. Production of a mutant strain (DLp4hnr::hph)
deficient in the enzyme 1,3,6,8-tetrahydroxynapthalene reductase that catalyses step [2] of melanin
biosynthesis in the fungus (Figure 1A) was reported recently [38] and is included in this study for
comparison to the newly developed mutants. Targeted gene disruptions were carried out following
the split marker method [39]. For targeted replacement of the SCD-encoding gene SCD1, two
rounds of PCR were required to complete the process. In the first round PCR, the left (upstream)
(1.0-kb) and right (downstream) (0.9-kb) flanking regions of the SCD1 ORF were amplified using
primer pairs Lpscd1-LFF/Lpscd1-LFR and Lpscd1-RFF/Lpscd1-RFR designed to include an extension
complementary to the hygromycin phosphotransferase gene (HPH) conferring resistance to the
antibiotic hygromycin B (Table 1). The left and right fragments of the HPH gene were amplified
from pCB1004 with primer pairs HY split/M13F and M13R/YG split, respectively. In a second round
of PCR, the left flank was fused with one half of the hygromycin cassette (HY) (1.2-kb) and the
right flank with the other half (YG) (0.8-kb). The second round PCR products LF+HY (2.1-kb) and
RF+YG (1.7-kb) were used for protoplast transformation. Homologous recombination resulted in the
replacement of the SCD1 ORF with the functional HPH gene. Putative DLpscd1::hph mutants were
selected based on resistance to the antibiotic hygromycin B (600 µg/mL).
Table 1. Details of primer sequences used in this study.
Primer Name Sequence 51-31 Product
Lpscd1-F GATCGCCATCCCAGCCATCA Lpscd1 ORF
Lpscd1-R ACGTGGCAAGGGTTGGATCC Lpscd1 ORF
Lpscd1-LFF CGTCAGCTTTGGAAAACAAC Lpscd1 LF
Lpscd1-LFR GTCGTGACTGGGAAAACCCTGGCGACGGTAGCCATGTTTTCCGA Lpscd1 LF
Lpscd1-RFF TCCTGTGTGAAATTGTTATCCGCTTATCTGGCGTCAATCGGAAA Lpscd1 RF
Lpscd1-RFR ACATGTTGTTTTGCACGCTT Lpscd1 RF
HY split GGATGCCTCCGCTCGAAGTA Lpscd1 LF+HY
YG split CGTTGCAAGACCTGCCTGAA Lpscd1 YG+RF
M13F CGCCAGGGTTTTCCCAGTCACGAC -
M13R AGCGGATAACAATTTCACACAGGA -
Lppks1-F TCTCGGTTTCTCCATGCAAA Lppks1 ORF
Lppks1-R CCTGCACAAACAATTCGTTA Lppks1 ORF
Lppks1-LFF AATCAAGTCGCCAGGACCTT Lppks1 LF
Lppks1-LFR GTCGTGACTGGGAAAACCCTGGCGTTTGCATGGAGAAACCGAG Lppks1 LF
Lppks1-RFF TCCTGTGTGAAATTGTTATCCGCTGAGCTGTATCACTGAGACA Lppks1 RF
Lppks1-RFR GAGGCCATTCAAAGATCCCA Lppks1 RF
Lppks1-f1 TAGAACTAGTGGATCCGTCTCACATCGTCGTACTATAAT Lppks1 gene fragment
Lppks1-r1 CGGTATCGATAAGCTCGGCACTAGGATATAAACCCTCTT Lppks1 gene fragment
Lppks1-ComF GAGTTCTGCCGTCAGGGAAA Lppks1 probe
Lppks1-ComR GAAGATGTGGCGCATGGTAG Lppks1 probe
The reverse complement of M13 forward and reverse sequences, used with HY split and YG split respectively,
are shown underlined. ORF: open reading frame; LF: left flank; RF: right flank; LFF: left flank forward; LFR: left
flask reverse; RFF: right flank forward; RFR: right flank reverse.
Targeted replacement of the PKS1 gene was performed using a similar experimental strategy.
Primer pairs Lppks1-LFF/Lppks1-LFR and Lppks1-RFF/Lppks1-RFR were used for amplification
of 1.9-kb fragments from 51 and 31 flanks of the ORF respectively. The left and right fragments of the
HPH gene were amplified as described. In a second round of PCR, the left flank was fused with one
half of hygromycin cassette (HY) (1.2-kb) and the right flank with the other half of the hygromycin
cassette (YG) (0.8-kb). The second round PCR products LF+HY (3.1-kb) and RF+YG (2.7-kb) were used
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for protoplast transformation. Homologous recombination resulted in the replacement of the PKS1
ORF with the functional HPH gene. Putative DLppks1::hphmutants were similarly selected based on
resistance to 600 µg/mL of the antibiotic hygromycin B.
2.2. Confirmation of Gene Disruptions by Southern Blotting and Abnormal Melanisation
Hygromycin B resistant mutants were investigated further by Southern blot analysis. A single
putative DLpscd1::hph mutant and six DLppks1::hph putative mutants were analysed (Figure 1).
Genomic DNA from the putative DLpscd1::hph mutant and the wild-type strain 3.1 were digested
with the restriction enzyme BglII and the enzyme HpaI for putative DLppks1::hph transformants and
wild-type strain 3.1 control. The products were separated by agarose gel electrophoresis (Figure 1B,G,
respectively) and blotted onto Hybond-NX membranes (Figure 1C,H, respectively). Respective
membranes were probed with a 1.0-kb fragment upstream of the SCD1 ORF (Figure 1C) or a 1.9-kb
right flank fragment of the PKS1 ORF (Figure 1H). The single putative DLpscd1::hphmutant (Figure 1C,
lane 3) showed the correct fragment size of 6.9-kb compared to the 5.6-kb fragment of the wild-type
strain (Figure 1C, lane 1), while two DLppks1::hphmutants (Figure 1H, lanes 5 and 7 indicated by white
asterisks) were identified with the correct fragment size of 5.6-kb compared to the 6.5-kb fragment of
the wild-type strain (Figure 1H, lane 1 indicated by black asterisk). Targeted disruption of the melanin
biosynthesis gene SCD1 encoding the melanin biosynthesis enzyme scytalone dehydratase and PKS1
encoding the enzyme polyketide synthase resulted in abnormal pigmentation in the DLpscd1::hph
and DLppks1::hph mutants when compared to the wild-type strain 3.1. The wild-type 3.1 strain is
grey (Figure 1D,I) in contrast to the beige colour of the DLpscd1::hph mutant (Figure 1E), while the
tetrahydroxynaphthalene reductase-deficient mutant DLp4hnr1::hph mutant (Figure 1F), generated
in a previous study [38], is yellow-grey. The two DLppks1::hphmutants confirmed in Southern blots
(Figure 1H, lanes 5 and 7) were albino (white), exhibiting complete loss of pigmentation (Figure 1J;
the DLppks1::hphmutant corresponding to lane 7 is panel H is shown) compared to the grey wild-type
strain 3.1.
2.3. Complementation of the DLppks1::hph Mutant and Restoration of Melanin Production
An albino DLppks1::hphmutant (Figure 1H, lane 7) was complemented by integration of a DNA
fragment consisting of 3.0-kb of promoter region, 6.7-kb of the ORF and 0.6-kb terminator region of the
PKS1 gene to restore gene functionality and concomitant melanin biosynthesis. The PKS1 fragment
was amplified by PCR using the gene-specific primers Lppks-f1 and Lp-pksr1 (Table 1), designed
to include 15-bp of sequence homologous to the ends of the linearized vector pCB1532. The vector
pCB1532, which contains the sulfonylurea resistance allele of theMagnaporthe oryzae ILV1 gene [40],
was linearized by digestion with the restriction enzymes BamHI and HindIII. The PCR product was
ligated to linearized pCB1532 vector and used to transform competent E. coli cells, which were selected
based on white-blue screening. Plasmid DNA was purified and sequenced to confirm the correct PKS1
insertion and the vector then transformed into the DLppks1::hphmutant. Putative DLppks1::hph:PKS
complementation mutants were selected based on resistance to sulfonylurea. Genomic DNA of
wild-type 3.1, DLppks1::hph and putative complemented mutants was digested with the restriction
enzyme BglII, fractionated by gel electrophoresis (Figure 1K) and blotted onto a Hybond-NXmembrane
(Figure 1L). The membrane was probed with a 0.8-kb fragment of the PKS1 ORF. The probe hybridized
to a 7.3-kb fragment present in the wild-type 3.1 and complemented strains (Figure 1L, lanes 1 and
4), which was absent in the two DLppks1::hphmutants (Figure 1L, lanes 2 and 3). Complementation
of the polyketide synthase-deficient mutant restored melanin production (Figure 1M), resulting in
a grey phenotype in the DLppks1::hph:PKS complementation mutant similar to the wild-type strain 3.1
(Figure 1D,I).
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2.4. Growth, Sporulation and Spore Pigmentation
Growth of the fungi on OA revealed no significant differences in growth rates compared to
strain 3.1, with the exception of mutant DSp4hnr::hph. With this mutant, there was a significant
reduction in colony diameter by day 14 compared to the wild-type strain (Figure 2A), consistent with
previous findings [38]. While spore production in the 14-day-old cultures was not significantly different
between strain 3.1 and mutants DLppks1::hph and DLppks1::hph:PKS, production was significantly
reduced in the mutant DLp4hnr::hph and significantly increased in the mutant DLpscd1::hph when
compared to the wild-type strain (Figure 2B). Spore suspensions prepared from the 14-day-old
cultures showed marked differences in pigmentations. Spore suspensions from strain 3.1 were
black-brown, whereas those from the albino mutant DLppks1::hphwere white (Figure 2C). Spores of
the complemented strain DLppks1::hph:PKS were black-brown, showing that complementation had
restored melanin biosynthesis resulting in a similar spore pigmentation to that of the wild-type strain.
The mutant DLpscd1::hph produced orange-yellow spore suspensions similar to that of the DLp4hnr::hph
generated previously [38].
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Figure 2. Phenotypic characterization of L. prolificans 3.1 and melanin mutants. (A) Colony diameters of
fungi grown on OA for 14 days. By day 14, the mutant DLp4hnr::hph had significantly reduced growth
when compared to the wild-type strain (p < 0.05; Student’s t-test). All other mutants showed growth
comparable to strain 3.1 over the 14 day period. Each point is the mean of 3 replicates ˘ standard error;
(B) Quantification of spore concentrations from 14-day-old OA plate cultures. Spore concentration
of the mutant DLp4hnr::hphwas significantly reduced (p < 0.05, analysis of variance (ANOVA)) when
compared to strain 3.1 and the other mutants, whereas sp re concentrati n was significantly increased
in the mutant DLpscd1::hphwhen compar d to the othe strains. There were no significant differences
in the spore concentrations of stra ns 3.1, DLppks1::hph and DLppks1::hph:PKS. Each bar is th mean of
3 replicat s ˘ standard error and bars with similar letters indicate that differences in means are not
statistically significant at p < 0.05 (ANOVA); (C) Colors of spore suspensions of L. prolificans 3.1 and the
mutants DLppks1::hph, DLppks1::hph:PKS and DLpscd1::hph.
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Figure 3. Sensitivities of L. prolificans 3.1 and melanin mutants to UV, H2O2 and the antifungal drug
amphotericin B. (A) Sensitivities of spores to oxidative killing by H2O2. Spores were exposed to 160 mM
H2O2 or phosphate buffer only (control) for 60 min and then plated onto SDA. After incubation in the
dark for 3 day at 30 ˝C, the number of colonies derived from germinated spores were counted and the
% survival for each strain determined relative to matched controls (untreated spores). Each bar is the
mean of 3 replicates ˘ standard error and bars with similar letters indicate that differences in means
are not statistically significant at p < 0.05 (ANOVA). Under these conditions, ~50% of treated spores of
the wild-type strain 3.1 survived compared to matched control spores. Compared to strain 3.1, there
was a significant reduction in % survival of mutants DLppks1::hph and DLp4hnr::hph due to exposure
to H2O2. There was no significant effect of H2O2 on the survival of mutant DLpscd1::hph or on the
survival of DLppks1::hph:PKS compared to 3.1, showing that complementation of mutant DLppks1::hph
had restored spore survival to wild-type levels; (B) Sensitivities of spores to UV light. Spores were
exposed to a UV dose of 200 mJ/cm2 and then plated onto SDA. After incubation in the dark for
3 days at 30 ˝C, the number of colonies derived from germinated spores were counted and the %
survival for each strain determined relative to matched controls (untreated spores). Each bar is the
mean of 3 replicates ˘ standard error and bars with similar letters indicate that differences in means
are not statistically significant at p < 0.05 (ANOVA). Under these conditions, ~50% of treated spores
of the wild-type strain 3.1 survived compared to matched control spores. Compared to strain 3.1,
there was a significant reduction in % survival of mutant DLppks1::hph due to exposure to UV. There
was no significant effect of UV exposure on the survival of mutants DLpscd1::hph and DLp4hnr::hph.
Similarly, there was no significant difference in the % survival of DLppks1::hph:PKS spores compared to
3.1, showing that complementation of mutant DLppks1::hph had restored spore survival to wild-type
levels; (C) Sensitivities of strains to the polyene antifungal drug amphotericin B. Each bar is the mean
of 3 replicates ˘ standard error and bars with similar letters indicate that differences in means are
not statistically significant at p < 0.05 (ANOVA). The black bars are the controls lacking amphotericin
B and the open bars show growth in the presence of the drug. Growth (dry weight in mg) of the
drug-resistant wild-type strain 3.1 and mutant DLp4hnr1::hphwas unaffected by the drug. Similarly,
there was no significant difference in the growth of the complemented strain DLppks1::hph:PKS in the
presence and absence of the drug, showing that restoration of melanin biosynthesis re-established drug
insensitivity of the fungus to wild-type levels. In contrast, significant increases in growth were found
in the albino mutant DLppks1::hph and mutant DLpscd1::hph in the presence of the drug, while the drug
completely inhibited growth of the control pathogen Aspergillus fumigatus.
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2.5. Sensitivities to H2O2
Exposure of spores of strain 3.1 to 160 mM H2O2 for 60 min resulted in 50% survival relative
to its matched control (non-treated spores) (Figure 3A). When compared to the wild-type strain, the
same treatment resulted in significant (p < 0.05) reductions in survival of the mutants DLppks1::hph
and DLp4hnr::hph, with survival percentages relative to matched controls of 21% and 24% respectively.
There was no significant difference in the effect of H2O2 on survival of DLppscd1::hph spores when
compared to strain 3.1 with a percentage survival, relative to its matched control, of 45%. A similar
result was found with the mutant DLppks1::hph:PKS, with a percentage survival relative to its matched
control of 46%, indicating that complementation had restored survival to wild-type levels.
2.6. Sensitivities to UV Radiation
A UV dose of 200 mJ/cm2 resulted in 51% survival of strain 3.1 spores relative to non-irradiated
control spores (Figure 3B). Under the same treatment conditions, there was a significant (p < 0.05)
decrease in percentage survival of the mutant DLppks1::hph compared to the wild-type, with
a percentage survival of 28%. There was no significant difference in effect of UV irradiation on the
percentage survival of the mutants DLpscd1::hph and DLp4hnr::hph when compared to strain 3.1, with
percentages of 40% and 42% respectively. A similar result was found with the mutant DLppks1::hph:PKS,
with a percentage survival relative to its matched control of 63%, indicating that complementation had
restored survival to wild-type levels.
2.7. Sensitivities to Amphotericin B
All strains of L. prolificans tested to date are resistant to the broad-spectrum antifungal drug
amphotericin B [14,15]. Here, we tested the susceptibility of the wild-type strain 3.1 and the melanin
biosynthesis mutants to the drug and included, as a positive control, the drug-sensitive pathogen
Aspergillus fumigatus (AF293). We chose a concentration of 32 µg/mL, having first established that
strain 3.1 of the fungus is resistant to concentrations >16 µg/mL, consistent with other studies [13–18].
Growth (measured as dry weight of mycelium in mg) of the drug-resistant wild-type strain 3.1 and
mutant DLp4hnr1::hph was unaffected by the drug. Similarly, there was no significant difference in the
growth of the complemented strain DLppks1::hph:PKS in the presence and absence of the drug, showing
that restoration of melanin biosynthesis re-established drug insensitivity of the fungus to wild-type
levels. Unexpectedly, significant increases in growth were found in the albino mutant DLppks1::hph
and mutant DLpscd1::hph in the presence of the drug, while the drug completely inhibited growth of
the control pathogen Aspergillus fumigatus as expected.
3. Discussion
Lomentospora prolificans is a dematiaceous (melanised) fungus that causes life-threatening
disseminated infections in immunocompromised humans and patients with underlying respiratory
problems [1–12]. Disseminated infections known as scedosporiosis are caused by infectious propagules
(spores) of the fungus that are inhaled, germinate and infect the lungs due to impaired respiratory
immunity including loss of oxidative killing by macrophages and neutrophils. The pathogen displays
inherent resistance to many of the mold-active antifungal drugs used in the clinical setting including
the polyene amphotericin B [13–18]. The pigment melanin is an integral component of the fungal cell
wall conferring protection to stresses that involve cell damage such as UV radiation and reactive oxygen
species [22,25–30,32,33] and which has been shown in other human pathogenic fungi to contribute
to amphotericin B resistance [24,25,41]. In this study, we set out to investigate the role of melanin in
resistance of L. prolificans to UV radiation, to oxidative killing by H2O2, and inhibition by amphotericin
B. To do this, we used targeted disruption of melanin biosynthesis genes to generate mutants blocked
at different stages in the DHN-melanin pathway.
Int. J. Mol. Sci. 2016, 17, 444 9 of 18
In a previous study [38], we used targeted gene disruption to generate an L. prolificansmutant
(DLp4hnr::hph) lacking the DHN-melanin enzyme tetrahydroxynaphthalene reductase (4HNR) which
catalyzes the reduction of 1,3,6,8-THN to scytalone (Figure 1A, step [2]). In this study, we used
a similar process to generate additional mutants, DLppks1::hph and DLpscd1::hph, that lack polyketide
synthase (PKS1) and scytalone dehydratase (SCD1) enzyme activities, respectively. Furthermore,
we complemented the PKS-deficient mutant to restore melanin biosynthesis in the DLppks1::hph
mutant. The split marker technique of homologous recombination used here enables exchange of the
open reading frame (ORF) of the enzyme-encoding gene with the hygromycin B phosphotransferase
(HPH)-encoding gene, a selectable marker conferring resistance to the antibiotic hygromycin B.
The procedure was carried out by amplification and fusion of linear DNA fragments to create the
hygromycin-resistance cassette. A previous study had shown that the size of the sequences upstream
and downstream of the ORF affects transformation efficiency [42] and so the lengths of flanking
fragments used for homologous recombination were designed according to the size of each ORF.
For the PKS-encoding gene, the flanks were approximately 1.9-kb (left flank) and 1.9-kb (right flank)
owing to the large size of the PKS ORF (6.7-kb). In the case of the SCD-encoding gene, the flank sizes
were shorter (approximately 1.0-kb and 0.9-kb for left and right flanks respectively), owing to the
smaller size of the SCD ORF of approximately 0.7-kb.
Using this strategy, we were able to generate enzyme-deficient mutants that had abnormal
pigmentation due to disruption of normal DHN-melanin biosynthesis. Previously, Ruiz-Diez and
co-workers [43] used UVmutagenesis to generate melanin-deficient (mel´) mutants of L. prolificans that
had unstable white phenotypes that reverted to the olive-grey to black characteristic of the wild-type
strain, or mutants that had stable white phenotypes that varied in colony morphologies. Unlike UV
mutagenesis, which is a random mutation process, targeted gene disruption allowed us to mutate
individual enzyme-encoding genes involved in melanin biosynthesis in a highly specific way and to
generate stable enzyme-deficient mutants. In the case of DLpscd1::hph, colonies of the mutant were
beige while its spore suspensions were orange-yellow. A similar spore pigmentation was shown in
the DLp4hnr::hph mutant developed previously that accumulated flaviolin as a shunt product [38].
Wang and co-workers [44] produced reddish-brown mutants lacking the corresponding SCD1 gene in
the ascomyceteGrosmannia clavigera and showed this color was due to accumulation of the intermediate
scytalone. Targeted disruption of the L. prolificans PKS-encoding gene resulted in the production of
albino (white) DLppks1::hphmutants, similar to the white PKS-deficient mutants of Bipolaris oryzae and
A. fumigatus developed elsewhere [45,46]. Complementation of the albino DLppks1::hphmutant was
successfully achieved, resulting in a mutant DLppks1::hph:PKS with grey pigmentation similar to that
of the wild-type strain.
Changes to normal melanin production in fungi can alter their morphology. Tseng and
co-workers [47] showed that engineering the entomopathogen Metarhizium anisopliae to express
DHN-melanin biosynthesis genes increased spore germination, hyphal branching and appressorium
production. Mutants of the fungus Grosmannia clavigera with PKS and SCD gene disruptions had
albino and reddish-brown phenotypes respectively, but had no marked differences in morphology,
sporulation, or in vegetative growth compared to the wild-type strain. In the current study, vegetative
growth and was significantly reduced in the 4HNR-deficient mutant DLp4hnr::hph consistent with
previous results [38], while growth was unaffected in the other two mutants and in the complemented
strain DLppks1::hph:PKS. Spore production was reduced in DLp4hnr::hph and increased in DLpscd1::hph.
Melanin is known to contribute to the stress tolerances of fungi, including both plant and
human pathogens, conferring resistance to UV radiation [33] and to oxidation killing [22,26–29].
Kheder and co-workers [48] showed that spore germination and radial growth was dramatically
reduced in non-melanised strains of the plant pathogen Alternaria alternata compared to melanised
strains as a consequence of UV exposure, while another study demonstrated resistance to UV light
of melanised strains of the human pathogen Sporothrix schenckii compared to a melanin-deficient
mutant [49]. In human pathogenic fungi, melanin acts as a free radical scavenger [50] and is
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associated with increased tolerance to H2O2 in Cryptococcus neoformans, Aspergillus spp., S. schenckii and
Fonsecaea pedrosoi [26–30]. In this study, the albino DLppks1::hphmutant showed increased sensitivity
to UV and H2O2 in spore survival assays. Restoration of melanisation in the DLppks1::hph:PKS
complemented strain and increased survival of DLppks1::hph:PKS spores to wild-type levels following
UV and H2O2 exposure, shows that melanin provides protection against UV damage and tolerance to
oxidative killing in L. prolificans. In contrast, another study knocked down the polyketide synthase
gene in Penicillium marneffei and found no difference between the wild-type and the mutant in rates of
survival following exposure to UV light [51].
The resistance of L. prolificans to antifungal agents is well documented [13–18] and the contribution
of melanin to antifungal drug resistance has been investigated in other human pathogenic fungi.
Van Duin and co-workers [41] demonstrated the protective role of melanin in C. neoformans and
Histoplasma capsulatum against amphotericin B, with non-melanised C. neoformans strains showing
greater sensitivity to the drug than melanised strains [24]. Contrary to expectations, we found
that the albino mutant of L. prolificans generated here (DLppks1::hph) showed significantly increased
growth in the presence of amphotericin B, while complementation of the PKS gene in the mutant
DLppks1::hph:PKS bestowed insensitivity to the drug, similar to that of the wild-type strain 3.1.
The unexpected increase in growth of the albino mutant in the presence of the drug, a phenomenon
also found with the DLpscd1::hph mutant, is difficult to explain. Paradoxical increases in growth of
the human pathogens Candida albicans and Aspergillus fumigatus due to elevated concentrations of
the anti-fungal echinocandin drug caspofungin have been reported [52,53], but increased resistance
of fungi to a polyene anti-fungal drug as a consequence melanin deficiency has not previously been
demonstrated. Indeed, melanin deficient (mel´) strains L. prolificans generated by UVmutagenesis [43]
were shown to be as resistant to amphotericin B, nystatin and azoles as the wild-type parent.
Despite this, amphotericin B has been shown to increase the melanin content of melanoma cells [54].
An alternative explanation for the increased growth of mutants DLppks1::hph and DLpscd1::hphmight
be compensation for DHN-melanin loss through alternative pathways of melanin biosynthesis.
In addition to DHN-melanins, the ascomycete fungi Aspergillus fumigatus and A. nidulans are able to
synthesize pyomelanin and DOPA-melanin [55]. Similar synthetic capabilities might also be present in
L. prolificans. Notwithstanding this, we have shown that melanin does not contribute to the resistance
of L. prolificans to amphotericin B, consistent with the findings of Ruiz-Diez and co-workers [43].
In conclusion, we have shown using targeted deletion of melanin biosynthesis genes that melanin
confers L. prolificans with protection from oxidative killing by H2O2 and protection from UV radiation,
but is not involved in its resistance to the anti-fungal drug amphotericin B.
4. Materials and Methods
4.1. Fungal Culture
The Lomentospora prolificanswild-type strain 3.1 [38], gene disruption mutants and Aspergillus fumigatus
strain AF293 were grown routinely on oatmeal agar (OA; O3506, Sigma, Sigma-Aldrich, Poole, Dorset,
UK) or Sabouraud dextrose agar (SDA; Sabouraud dextrose broth (SBD; S3306, Sigma) containing
2% agar) at 30 ˝C under a 16 h fluorescent light regime to induce sporulation. Agar was sterilized by
autoclaving at 121 ˝C for 15 min.
4.2. Genomic DNA Extraction
DNA extraction was carried out according to the procedures described in Alastruey-Izquierdo and
co-workers [56]. Spores were harvested by flooding OA plate cultures with 20 mL sterile autoclaved
Milli-Q water (MQ-H2O) and suspension with a sterile L-shaped spreader (Fisher Scientific UK
Ltd., Loughborough, Leicestershire, UK). The suspension was filtered through sterile Miracloth
(Calbiochem, San Diego, CA, USA) to remove hyphal tissue, centrifuged at 13,000ˆ g to pellet spores
and the spores re-suspended in sterile MQ-H2O. Sterile 75 cm2 tissue culture flasks containing 100 mL
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of tissue culture medium (TCM; RPMI-1640 medium (R0883, Sigma) containing 10% fetal bovine
serum (Labtech International Ltd., Uckfield, East Sussex, UK), 2 mM L-glutamine (G7513, Sigma),
penicillin and streptomycin) were inoculated with spore suspension to give a final concentration of
104 spores/mL and incubated with shaking (35 rpm) in an Innova 4000 rotary incubator (Eppendorf
UK Ltd., Stevenage, Hertfordshire, UK) for 48 h at 30 ˝C. Hyphal biomass was harvested by filtration
through sterileMiracloth, washedwith sterileMQ-H2O, blotted drywith paper towel (Kimberley-Clark
Ltd., West Malling, Kent, UK) and stored at ´80 ˝C until required. Frozen mycelium was ground to
a fine powder in liquid N2 using a mortar and pestle, the powder transferred to 1.5 mLmicro-centrifuge
tubes and 800 µL of extraction buffer (0.2 M Tris–HCl, 0.5 M NaCl, 10 mM EDTA, SDS 1%) added
followed by 800 µL of phenol:chloroform:isoamyl alcohol mixture (25:24:1). The mixture was shaken
gently for 30 s and then centrifuged at 14,000ˆ g for 15 min at 4 ˝C. The upper layer was transferred to
a fresh tube and mixed with an equal volume of phenol:chloroform:isoamyl alcohol mixture (25:24:1),
vortexed for 30 s and centrifuged as described. The upper layer was combined with an equal volume
of chloroform:isoamyl alcohol (24:1) and vortexed for 30 s. Following centrifugation for 5 min at
14,000ˆ g, the upper layer was transferred to a fresh tube, the DNA precipitated by adding chilled
isopropanol and pelleted by centrifugation at 4 ˝C for 15 min at 14,000ˆ g. The pellet was washed
with 70% ethanol and centrifuged for a further 10 min at 14,000ˆ g. The pellet was dried for 15 min at
23 ˝C, re-suspended in 30 µL MQ-H2O containing RNAse and then incubated for 1 h at 37 ˝C. DNA
quality and quantity was determined by both agarose gel electrophoresis and by using a Nanodrop
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
4.3. Digestion of Plasmid and Genomic DNA with Restriction Enzymes
Restriction enzymes were obtained from Promega UK Ltd. (Southampton, Hampshire, UK) or
New England Biolabs (Ipswich, MA, USA). DNA (0.2–1.0 µg) was digested with 5 to 10 units of enzyme
in a total volume of 30 µL. For Southern blot analysis, digestion was performed by incubating 50 µg of
genomic DNA with 60 units of restriction enzyme in a total volume 50 µL. In both cases, the mixtures
were incubated at 37 ˝C for 16 h.
4.4. L. prolificans Genome and Primer Design
The full genome sequence of L. prolificans strain 3.1 archived at Biosciences, University of
Exeter [38] was used for primer design. Primers were constructed by using the online resource
(http://depts.washington.edu/bakerpg/primertemp/primermelttemp.html) and for reverse complements
(http://arep.med.harvard.edu/labgc/adnan/projects/Utilities/revcomp.html). The primers used in
this study are shown in Table 1.
4.5. Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) was used to amplify DNA fragments in an Applied Biosystems
GeneAmp® PCR System 2400 cycler (Applied Biosystems, Foster City, CA, USA). GoTaq® Green
Master Mix (Applied Biosystems, Foster City, CA, USA), Phusion High Fidelity DNA polymerase
(New England Biolabs, Ipswich, MA, USA) or Long PCR enzyme mix (Thermo Fisher Scientific,
Waltham, MA, USA) were used according to the manufacturer’s instructions. For GoTaq, the reaction
mixture contained 12.5 µL GoTaq Green Master Mix, 10 µM of forward and reverse primer, 50 ng of
genomic DNA and nuclease free water to a total volume of 50 µL and PCR cycling conditions were
an initial denaturation step at 98 ˝C for 3 min followed by 35 cycles at 98 ˝C for 1 min, 53.5–20 ˝C
(depending on annealing temperature of primers) for 1 min and at 72 ˝C, followed by a final extension
step at 72 ˝C for 10 min. Phusion High Fidelity DNA polymerase reaction mixture contained 5 µL of
5ˆ Phusion HF buffer, 0.5 µL of 10 mM dNTPs, 0.25 µL Phusion, 10 µM of forward and reverse primer,
50 ng of genomic DNA and nuclease-free water to a final volume of 50 µL. PCR cycling conditions
were an initial denaturation step at 98 ˝C for 30 s followed by 35 cycles of 98 ˝C for 10 s, 62 ˝C for 30 s
and 72 ˝C for 45 s, with a final extension for 10 min at 72 ˝C. Long PCR enzyme mix was used for PKS1
Int. J. Mol. Sci. 2016, 17, 444 12 of 18
gene amplification. The PCR reaction mixture contained 5 µL of 10ˆ Long PCR buffer with 15 mM
MgCl2, 1 µL of 10 mM dNTPs, 1 µL of 10 µM of forward and reverse primer, 50 ng of genomic DNA,
Long PCR enzyme mix to a total volume of 50 µL with nuclease-free water. PCR cycling conditions
were an initial denaturation step at 94 ˝C for 3 min, 10 cycles at 94 ˝C for 20 s, 50 ˝C for 30 s and 68 ˝C
for 7 min, followed by 25 cycles of 94 ˝C for 20 s, 50 ˝C for 30 s, 68 ˝C for 7 min. The final extension
step was at 68 ˝C for 1 min.
4.6. Electrophoresis and Purification of Genomic DNA and PCR Products
Agarose gel electrophoresis was used to fractionate digested DNA. The DNA was separated in
0.8% agarose gels and stained with ethidium bromide after mixing with loading dye (50 mL glycerol,
0.25 g bromophenol blue, 5 mL of 0.5 M EDTA (pH 8.0) and 45 mL MQ-H2O). Electrophoresis was
carried out in 1ˆ Tris-borate EDTA buffer (TBE; 0.09 M Tris-borate, 0.002 M EDTA) for 1 h at 100 V.
The DNA fragments were visualized using a UV transilluminator and fragment sizes was determined
by comparison with a 1-kb ladder (Promega). Gel images were captured by using an Image Master
VDS-CL gel documentation system (GE Healthcare Life Sciences, Little Chalfont, Buckinghampshire,
UK) fitted with a Fujifilm FTI-500 Thermal Imaging system (GE Healthcare). DNA fragments were
purified from agarose gels using Wizard® SV gel and PCR Clean-Up Systems (Promega) according to
the manufacturer’s instructions. Purified DNA was stored at ´20 ˝C until required.
4.7. DNA Ligation
Ligation of DNA fragments was carried out using the In-Fusion® HD Cloning kit (Clontech
Laboratories Inc., Mountain View, CA, USA) according to the manufacturer’s instructions. The ligation
reaction components were combined in a PCR tube in the following order: 2 µL 5ˆ In-Fusion HD
enzyme premix, 50 ng linearized vector, 200 ng purified PCR fragment and MQ-H2O to a total volume
of 10 µL. The cloning reaction was incubated at 50 ˝C for 15 min and then kept on ice until required.
4.8. Transformation of Competent Cells
Stellar competent Escherichia coli cells (Clontech) were thawed, placed on ice and mixed gently for
even distribution. Fifty-µL of component cells were combined gently with 5 ng (2.5 µL) of In-Fusion
cloning reaction. The tubes were incubated on ice for 30 min, heat-shocked at 42 ˝C for 45 s and
then transferred to ice for 1–2 min. SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl,
2.5 mM KCl, 10 mMMgCl2, 20 mM glucose) preheated to 37 ˝C was added to a total volume of 500 µL.
The tube was incubated for 1 h at 37 ˝C with shaking (200 rpm) in an Innova 4000 rotary incubator.
One hundred-µL were streaked on LB agar plates (LB broth (tryptone, 10 g/L, yeast extract, 5 g/L,
NaCl, 10 g/L, pH 7.5) containing 18 g/L agar) overlaid with X-Gal (40 µg/mL) and supplemented
with 1 mL of 100 µg/mL ampicillin. Plates were inverted and incubated at 37 ˝C for 16 h. Colonies
were selected based on white-blue screening.
4.9. Plasmid Isolation (Quick-Prep Method)
A single colony of transformed bacteria was used to inoculate 10 mL of LB broth containing 10 µL
of 100 µg/mL ampicillin. The culture was incubated overnight at 37 ˝C with shaking (180 rpm)
in an Innova 4000 rotary incubator (Eppendorf). A 1 mL aliquot of culture was transferred to
a micro-centrifuge tube and, after centrifugation at 13,000ˆ g for 1 min, the supernatant was discarded
and the pellet re-suspended in 100 µL lysis solution (250 µL 1 M Tris-HCl (pH8.0), 200 µL 0.5 M EDTA,
170 µL, 60% sucrose, 2.4 mL MQ-H2O) and vortexed. Two hundred-µL of alkaline solution (100 µL
10 M NaOH, 500 µL 10% SDS, 4.4 mL MQ-H2O) was added and the samples were placed on ice for
10 min with occasional shaking. One hundred and fifty-µL of 3 M sodium acetate (pH 5.2) were added
and the samples were incubated on ice for a further 10 min and then centrifuged (13,000ˆ g) for 10 min
at 4 ˝C. The supernatant was transferred to a fresh tube containing 1 mL of 100% ethanol and stored
on ice for 10 min before centrifugation at 13,000ˆ g for 10 min. This process was repeated with 70%
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ethanol, the pellet dried at 23 ˝C and then re-suspended in 30 µL of MQ-H2O containing 7 µL RNase
(10 mg/mL). The DNA was stored at ´20 ˝C until used.
4.10. Plasmid DNA Isolation (Midi-Prep Method)
High quality plasmid DNA was isolated using the PureYield™ Plasmid Midiprep System
(Promega) according to the manufacturer’s instructions. A single colony of bacterial cells was grown in
50 mL LB containing 1 mL of a 100 µg/mL ampicillin solution for 16 h at 37 ˝C with shaking (180 rpm)
in an Innova 4000 rotary incubator (Eppendorf). The cells were centrifuged at 5,000ˆ g for 10 min
and the supernatant discarded. The pellet was re-suspended in 3 mL of cell re-suspension solution
(50 mM Tris (pH 7.5), 10 mM EDTA, and 100 µg/mL of RNase). Three-mL of cell lysis solution (0.2 M
NaOH, 1% (w/v) SDS) were added and the contents of the tube were mixed by inverting 3–2 times.
After 3 min incubation at 23 ˝C, 5 mL of neutralization solution (4.09 M guanidine hydrochloride,
0.759 M potassium acetate, 2.12 M glacial acetic acid, pH 4.2) was added, the tube was inverted
5–20 times and the lysate centrifuged at 14,000ˆ g for 15 min. The PureYield™ purification system
was used to purify DNA according to the manufacturer’s instructions and DNA stored at ´20 ˝C
until required.
4.11. Protoplast Transformation
Spores were harvested from 2-week-old OA cultures, inoculated into 100 mL TCM and incubated
for 3 days at 30 ˝C with shaking (35 rpm) in an Innova 4000 rotary incubator. Hyphal biomass
was harvested by filtration through Miracloth and washed and dried as described. The mycelium
was transferred to a 50 mL Falcon tube containing 40 mL OM buffer/Glucanex (44 g MgSO4¨ 7H2O,
1.5 mL 10 mM NaPO4, 1.8 g of 5% Glucanex (Novo Nordisk, Copenhagen, Denmark), pH 5.6) and
incubated at 30 ˝C with shaking (75 rpm) for 3 h. The contents of the tube were transferred to sterile
polycarbonate Nalgene Oakridge tubes (Thermo Fisher) and the protoplasts were overlaid with chilled
ST buffer (0.6 M Sorbitol and 0.1 M Tris-HCl (pH 7.0)). The protoplasts were centrifuged at 5000ˆ g
for 15 min at 4 ˝C using a swinging bucket rotor (Beckman JS-13.1, Beckman Coulter Inc., Brea, CA,
USA) in a Beckman J2.MC centrifuge (Beckman Coulter). The protoplasts were recovered at the
OM/ST interface and transferred to a sterile Oakridge tube, which was filled with cold STC buffer
(1.2 M Sorbitol, 10 mM Tris-HCl (pH 7.5), 10 mM CaCl2). Protoplasts were pelleted at 3000ˆ g for
10 min at 4 ˝C and washed twice with 10 mL STC, with complete re-suspension each time. Protoplasts
were re-suspended in 1 mL STC and numbers quantified using a haemocytometer. Protoplasts were
combined with 3 µg DNA in a sterile micro-centrifuge tube in a final volume of 150 µL and incubated
for 15 min at 23 ˝C. One-mL of PTC (60% PEG4000, 10 mM Tris-HCl (pH 7.5), 10 mMCaCl2) was added
and the contents were mixed by gentle inversion. The protoplasts were incubated at 23 ˝C for 15 min,
added to 150 mL molten (45 ˝C) OCM agar (osmotically stabilized CM; 50 mL nitrate salt solution,
1 mL trace elements (22 mg/L zinc sulphate heptahydrate, 11 mg/L boric acid, 5 mg/L manganese(II)
chloride tetrahydrate, 5 mg/L iron(II) sulphate heptahydrate, 1.7 mg/L cobalt(II) chloride hexahydrate,
1.6 mg/L copper(II) sulphate pentahydrate, 1.5 mg/L sodium molybdate dehydrate, 50 mg/L EDTA),
10 g glucose, 2 g peptone, 1 g yeast extract, 1 g casamino acids, 1 mL vitamin solution (0.001 g/L, biotin,
0.001 g/L, pyridoxine, 0.001 g/L, thiamine, 0.001 g/L riboflavin, 0.001 g/L, 0.001 g/L nicotinic acid),
273.84 g sucrose and 15 g agar in a final volume of 1 L, adjusted to pH 6.5 with 1 M NaOH) and the
protoplast suspension poured into sterile 9 cm plastic culture dishes for incubation in the dark at 30 ˝C
for 16 h. The plates were then overlaid with complete medium (CM; 10 g/L glucose, 2 g/L, peptone,
1 g/L, yeast extract (BD Biosciences UK, Oxford, Oxfordshire, UK), 1 g/L casamino acids, 0.1% trace
elements, 0.1%, 0.1% vitamin solution, 6 g/L NaNO3, 0.5 g/L, KCl, 0.5 g/L, MgSO4, 1.5 g/L, KH2PO4,
(pH to 6.5 with NaOH), 15 g/L agar) containing 600 µg/mL hygromycin B (Calbiochem) and were then
incubated for 1 week in the dark at 30 ˝C. Colonies resistant to hygromycin B were sub-cultured on
CM containing 200 µg/mL hygromycin B and finally onto OA. For selection of sulfonylurea-resistant
transformants, CM was replaced with BDCMmedium (yeast nitrogen base without amino acids and
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ammonium sulfate, agar 1.7 g/L, ammonium nitrate, 2 g/L, asparagine, 1 g/L, glucose, 10 g/L, sucrose,
0.8 M, pH 6.0) with chlorimuron ethyl at a concentration of 300 µg/mL in the overlay, chlorimuron
ethyl at a concentration of 100 µg/mL in BDCM sub-cultures and finally growth on OA.
4.12. Southern Blotting
Southern blotting was carried out according to the protocol of Southern [57]. Thirty-µg of genomic
DNA was digested overnight using an appropriate restriction enzyme. The products of digestion
were separated on 0.8% agarose gels at 100 V for 3 h. Gels were immersed in 0.25 M HCl for 15 min,
followed by 0.4 M NaOH for a further 15 min, for de-purination and neutralization respectively.
Gel blots were carried out by placing gels onto Whatman 3 mm paper wetted with 0.4 M NaOH and
supported by a Perspex sheet with the ends of the paper immersed in 0.4 M NaOH. Gels were covered
with Hybond-NX membrane (GE Healthcare Life Sciences), two layers of Whatman 3 mm paper and
paper towel (Kimberley Clark). Finally, a 500 g weight was placed on the blotted gel and the blot was
incubated for 16 h at 23 ˝C. Transferred DNA was UV-cross linked to the membrane using a BioLink
BLX crosslinker (Sigma-Aldrich).
DNA probes were amplified by using Phusion HF buffer and the appropriate primers shown in
Table 1 and reaction mixtures labelled with PCR DIG labelling mix (Sigma-Aldrich). Membranes were
incubated in Hybaid hybridization bottles (Thermo Fisher) in a hybridization oven (Thermo Fisher)
with Southern hybridization buffer (500 mL 1 M NaPO4 (pH 7.0), 350 mL 20% SDS and Seradest added
to a final volume of 1 L) at 62 ˝C for 30 min. Probes were denatured by boiling for 10 min and then
added to hybridization bottles containing the membranes. Following hybridization at 62 ˝C for 16 h,
the membranes were washed twice (15 min each) at 62 ˝C with Southern wash buffer (100 mL 1 M
NaPO4 (pH 7.0), 50 mL 20% SDS and MQ-H2O to 1 L) and once at 23 ˝C using 20 mL DIG wash buffer
1 (6 mL Tween-20, 1.994 mL DIG buffer (maleic acid 0.1 M, NaCl 0.15 M, adjusted to pH 7.5 with
5 M NaOH) and with MQ-H2O added to 2 L) for 5 min. Membranes were submerged in 50 mL of
blocking buffer (1 g semi-skimmed milk powder and 100 mL DIG buffer 1) for 30 min at 23 ˝C and then
incubated with 50 mL of antibody solution (2.5 µL anti-digoxigenin-AP Fab fragments (Sigma-Aldrich)
and 50 mL blocking buffer) under the same conditions. After two 15 min washes with DIG wash buffer
and equilibriation with 20 mL DIG buffer 3 (200 mL of 1 M Tris-HCl, 40 mL of 5 M NaCl, 100 mL of
1 M MgCl2 (pH 9.5) with MQ-H2O added to 2 L) for 5 min, membranes were incubated for 5 min with
2 mL CDP-star® chemiluminescent substrate solution (Sigma-Aldrich) and dried completely. Finally,
the membrane was exposed to X-ray film (Fuji Photo Film (UK) Ltd., Manchester, Cheshire, UK) placed
in a film cassette and incubated at 37 ˝C for 15 min. Films were developed using an OPTIMA X-Ray
Film Processor (Protec GmbH, Oberstenfield, Germany).
4.13. Hyphal Growth, Sporulation and Spore Pigmentation
Strains were inoculated centrally onto replicate OA plates and colony diameters were measured
over a 2-week growth period at 30 ˝C, with spore production quantified after 14 day. Spores were
suspended in 20 mL dH2O using plastic L-shaped spreaders, filtered through Miracloth, and spore
concentrations determined using a haemocytometer. There were 3 replicates for each experiment and
experiments were repeated 3 times.
4.14. Oxidative Killing by H2O2
Preliminary investigations set out to establish the molarity and exposure time to H2O2 that
resulted in a 50% reduction in survival of the wild-type strain 3.1. Replicate spore suspensions with
a concentration of 103 spores/mL were suspended in 100 mM phosphate buffer (pH 7.0) comprising
a range of mM concentrations of H2O2. Following exposure, 300 µL of spore suspensions were spread
on the surface of SDA plates and incubated for 3 day at 30 ˝C in the dark. The control consisted
of untreated spores (suspended in buffer only) and percentage survival was determined from the
numbers of colonies that developed from treated spores compared to the untreated control. Through
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this process it was determined that exposure of spores to 160 mM H2O2 for 60 min resulted in 50%
survival of treated spores of the wild-type compared to the matched untreated control. All subsequent
experiments using mutant strains were conducted using this same treatment regime and percentage
survival relative to matched controls determined as described. There were 3 replicates for each strain
and experiments were conducted three times.
4.15. Sensitivity to UV Radiation
Preliminary investigations aimed to establish the UV dose at 254 nm that resulted in a 50%
reduction in survival of the wild-type strain 3.1. Replicate spore suspensions with a concentration
of 103 spores/mL were exposed to UV light generated by a HL-2000 HybriLinker Hybridization
oven (UVP) with doses of 100, 200, 300, 400 and 500 mJ/cm2. Following exposure, 300 µL of spore
suspensions were spread on the surface of SDA plates and incubated for 3 days at 30 ˝C in the dark.
The control consisted of non-irradiated spores and percentage survival was determined from the
numbers of colonies that developed from irradiated spores compared to the non-irradiated control.
Through this process it was determined that a UV dose of 200 mJ/cm2 resulted in 50% survival of
irradiated spores of the wild-type compared to the matched non-irradiated control. All subsequent
experiments using mutant strains were conducted at this dose and percentage survivals relative to
matched controls determined as described. There were 3 replicates for each strain and experiments
were conducted three times.
4.16. Sensitivity to Amphotericin B
The sensitivities of the mutants and strain 3.1 to the polyene amphotericin B (AmB; Sigma,
A2942) were tested using a liquid culture method. Tissue culture medium was amended with
a liquid formulation of AmB (Sigma; A2942) to give final concentration of 32 µg/mL and the control
consisted of TCM amended with an equivalent volume of sterile MQ-H2O only. Tissue culture flasks
(75 cm2) containing AmB or control media were inoculated with spores of the L. prolificans strains,
or the drug-sensitive pathogen Aspergillus fumigatus (strain AF293), to give a final concentration
of 106 spores/mL. Flasks were incubated for 3 days at 30 ˝C with shaking (48 rpm) in an Innova
4000 rotary incubator and the mycelium was harvested, dried at 70 ˝C for 48 h and dry weights
obtained. The experiment was repeated three times with three replicates for each strain and treatment.
4.17. Statistical Analysis
Unless otherwise stated, numerical data were analyzed using the statistical program Minitab
(Minitab 16, Minitab®, Coventry, UK). Analysis of variance (ANOVA) was used to compare means
of more than two data sets and Post-hoc Tukey-Kramer analysis was then performed to distinguish
which sets were significantly different from one another. For comparisons of percentages, data was
transformed using the arcsin´1 function prior to statistical analysis.
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